Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JHS Svendgaard Laboratories Ltd. Call Transcript 2022

Nov 10, 2022

61621_rns_2022-11-10_d4c08ace-3fd8-4423-bd0c-e2d9ce834b60.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [141 x 104] intentionally omitted <==

CIN : L74110HP2004LC027558

November 10, 2022

To

The Listing Department Bombay Stock Exchange Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400 001

The Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Mumbai – 400 051 Trading Symbol: JHS

Scrip Code: 532771

Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and - Disclosure Requirements) Regulations, 2015 Intimation of Earnings Conference Call

Pursuant to Regulation 30(6) and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Conference Call for the analysts and investors to discuss the financial and operational performance of the Company for Q2 FY 2023 is scheduled to be held on Tuesday, November 15, 2022 at 04:00 PM IST. Further details are enclosed herewith.

Please note that the above shall be subject to changes in case of exigencies, if any, on the part of Investors/Company.

The transcript of the aforesaid call shall be submitted to the Stock Exchange and placed on the website of the Company https://www.svendgaard.com.

This is for your information and records.

For JHS Svendgaard Laboratories Limited Digitally signed ASHISH by ASHISH GOEL Date: 2022.11.10 GOEL Ashish Goel 16:56:17 +05'30' Chief Financial Officer

Enclosed:Details

==> picture [560 x 57] intentionally omitted <==

==> picture [97 x 60] intentionally omitted <==

JHS Svendgaard Laboratories Limited

Cordially invites you to the

Earnings Conference Call

To discuss the operational and financial performance for Q2 & H1 FY23

Day/Date: Tuesday 15[th] November 2022 Time: 04:00 PM

==> picture [433 x 124] intentionally omitted <==

----- Start of picture text ----- Access NumbersUniversal Dial in +91 22 6280 1341+91 22 7115 8242Hong Kong 800 964 448Singapore 800 101 2045UK 0808 101 1573USA 1866 746 2133----- End of picture text -----

Diamond Pass Link:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=05 05001&linkSecurityString=26acddb7e

JHS Svendgaard Laboratories will be represented by:

Mr. Nikhil Nanda

Founder & Managing Director

Mr. Ashish Goel

Chief Financial Officer

We look forward to your participation

RSVP

Savli Mangle Bridge Investor Relations Pvt. Ltd. Contact: +91 98333 61003